Literature DB >> 20042692

Bmp2 and Bmp4 exert opposing effects in hypoxic pulmonary hypertension.

Lynda Anderson1, Jonathan W Lowery, David B Frank, Tatiana Novitskaya, Mark Jones, Douglas P Mortlock, Ronald L Chandler, Mark P de Caestecker.   

Abstract

The bone morphogenetic protein (BMP) type 2 receptor ligand, Bmp2, is upregulated in the peripheral pulmonary vasculature during hypoxia-induced pulmonary hypertension (PH). This contrasts with the expression of Bmp4, which is expressed in respiratory epithelia throughout the lung. Unlike heterozygous null Bmp4 mice (Bmp4(LacZ/+)), which are protected from the development of hypoxic PH, mice that are heterozygous null for Bmp2 (Bmp2(+/-)) develop more severe hypoxic PH than their wild-type littermates. This is associated with reduced endothelial nitric oxide synthase (eNOS) expression and activity in the pulmonary vasculature of hypoxic Bmp2(+/-) but not Bmp4(LacZ/+) mutant mice. Furthermore, exogenous BMP2 upregulates eNOS expression and activity in intrapulmonary artery and pulmonary endothelial cell preparations, indicating that eNOS is a target of Bmp2 signaling in the pulmonary vasculature. Together, these data demonstrate that Bmp2 and Bmp4 exert opposing roles in hypoxic PH and suggest that the protective effects of Bmp2 are mediated by increasing eNOS expression and activity in the hypoxic pulmonary vasculature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042692      PMCID: PMC2838658          DOI: 10.1152/ajpregu.00534.2009

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  32 in total

1.  Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.

Authors:  M Oelze; H Mollnau; N Hoffmann; A Warnholtz; M Bodenschatz; A Smolenski; U Walter; M Skatchkov; T Meinertz; T Münzel
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

Review 2.  The transforming growth factor-beta superfamily of receptors.

Authors:  Mark de Caestecker
Journal:  Cytokine Growth Factor Rev       Date:  2004-02       Impact factor: 7.638

3.  Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse.

Authors:  P S Jat; M D Noble; P Ataliotis; Y Tanaka; N Yannoutsos; L Larsen; D Kioussis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.

Authors:  N W Morrell; X Yang; P D Upton; K B Jourdan; N Morgan; K K Sheares; R C Trembath
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

5.  BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

Authors:  R D Machado; M W Pauciulo; J R Thomson; K B Lane; N V Morgan; L Wheeler; J A Phillips; J Newman; D Williams; N Galiè; A Manes; K McNeil; M Yacoub; G Mikhail; P Rogers; P Corris; M Humbert; D Donnai; G Martensson; L Tranebjaerg; J E Loyd; R C Trembath; W C Nichols
Journal:  Am J Hum Genet       Date:  2000-12-12       Impact factor: 11.025

6.  eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia.

Authors:  T R Quinlan; D Li; V E Laubach; E G Shesely; N Zhou; R A Johns
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-10       Impact factor: 5.464

7.  Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action.

Authors:  Masaya Takeda; Fumio Otsuka; Kazufumi Nakamura; Kenichi Inagaki; Jiro Suzuki; Daiji Miura; Hideki Fujio; Hiromi Matsubara; Hiroshi Date; Tohru Ohe; Hirofumi Makino
Journal:  Endocrinology       Date:  2004-06-10       Impact factor: 4.736

8.  Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells.

Authors:  Shen Zhang; Ivana Fantozzi; Donna D Tigno; Eunhee S Yi; Oleksandr Platoshyn; Patricia A Thistlethwaite; Jolene M Kriett; Gordon Yung; Lewis J Rubin; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-05-09       Impact factor: 5.464

Review 9.  The sequence of cellular and hemodynamic changes of chronic pulmonary hypertension induced by hypoxia and other stimuli.

Authors:  B O Meyrick; E A Perkett
Journal:  Am Rev Respir Dis       Date:  1989-11

10.  Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.

Authors:  James West; Karen Fagan; Wolfgang Steudel; Brian Fouty; Kirk Lane; Julie Harral; Marloes Hoedt-Miller; Yuji Tada; John Ozimek; Rubin Tuder; David M Rodman
Journal:  Circ Res       Date:  2004-03-18       Impact factor: 17.367

View more
  24 in total

1.  EXPRESS: Gremlin1 blocks vascular endothelial growth factor signalling in the pulmonary microvascular endothelium.

Authors:  Simon Coyle Rowan; Lucie Piouceau; Joanna Cornwell; Lili Li; Paul McLoughlin
Journal:  Pulm Circ       Date:  2018-10-04       Impact factor: 3.017

Review 2.  BMP signaling in vascular development and disease.

Authors:  Jonathan W Lowery; Mark P de Caestecker
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-31       Impact factor: 7.638

Review 3.  Cellular Pathways Promoting Pulmonary Vascular Remodeling by Hypoxia.

Authors:  Larissa A Shimoda
Journal:  Physiology (Bethesda)       Date:  2020-07-01

4.  Genotype-phenotype effects of Bmpr2 mutations on disease severity in mouse models of pulmonary hypertension.

Authors:  Andrea L Frump; Arunima Datta; Sampa Ghose; James West; Mark P de Caestecker
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

5.  Bone morphogenetic protein 2 decreases TRPC expression, store-operated Ca(2+) entry, and basal [Ca(2+)]i in rat distal pulmonary arterial smooth muscle cells.

Authors:  Yi Zhang; Wenju Lu; Kai Yang; Lei Xu; Ning Lai; Lichun Tian; Qian Jiang; Xin Duan; Minsheng Chen; Jian Wang
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-27       Impact factor: 4.249

Review 6.  Vascular remodeling in pulmonary hypertension.

Authors:  Larissa A Shimoda; Steven S Laurie
Journal:  J Mol Med (Berl)       Date:  2013-01-19       Impact factor: 4.599

Review 7.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

8.  Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility.

Authors:  Paul Andrew Muller; Balázs Koscsó; Gaurav Manohar Rajani; Korey Stevanovic; Marie-Luise Berres; Daigo Hashimoto; Arthur Mortha; Marylene Leboeuf; Xiu-Min Li; Daniel Mucida; E Richard Stanley; Stephanie Dahan; Kara Gross Margolis; Michael David Gershon; Miriam Merad; Milena Bogunovic
Journal:  Cell       Date:  2014-07-17       Impact factor: 41.582

9.  Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Jarrod W Barnes; Elif T Kucera; Liping Tian; Noël E Mellor; Nina Dvorina; William W Baldwin; Micheala A Aldred; Carol F Farver; Suzy A A Comhair; Metin Aytekin; Raed A Dweik
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

10.  Cardiac responses to 24 hrs hyperoxia in Bmp2 and Bmp4 heterozygous mice.

Authors:  R Howden; I Cooley; C Van Dodewaard; S Arthur; S Cividanes; L Leamy; K McCann Hartzell; W Gladwell; J Martin; G Scott; M Ray; Y Mishina
Journal:  Inhal Toxicol       Date:  2013-07-22       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.